By using a US-patented DNA microarray technology, GoodGene has developed a novel DNA microarray which can detect clinically important respiratory virus in entirety which can infect human or both human and animals. This Pan-Res Virus DNA chip can detect and genotype respiratory viruses including influenza viruses, respiratory syncytial viruses, adenoviruses, rhinoviruses, coronaviruses, and COVID-19. It is a semi-automated assay. It takes around 3 hours for two or three laboratory scientists to test hundreds of sample.

The DNA chips can analyze the 40 types of HPV found in cervical, diagnose complex infection by at least one type of HPV, and have excellent diagnostic sensitivity and specificity on HPV genetic type up to 100% and reproducibility. Also, the DAN chips are superior to conventional analytic method, and very economical, since they can analyze numerous specimens in shortest time. Accordingly, the DNA chips are useful for predicting cervical cancer and precancerous lesion.

The CTC Gene Expression Analysis is comprised of Real-Time PCR testing of cancer markers and microarray testing of cancer markers. Real-time PCR is the gold-standard technique for verification of differential gene expression profiles. Our comprehensive offering of TaqMan Gene Expression Assays and flexible formats enables fast and cost-effective results. Microarrays are designed with up-to-date content from public sequence data sources, and enable fast, detailed transcriptome-wide expression profiling, even from challenging and precious samples with no bioinformatics resources required.